PER-046-04已完成未知
COMPARATIVE STUDY OF PHASE III RANDOMIZED, DOUBLE-BLIND TWO REGIMES OF DOSE OF MICAFUNGIN (FK463) VERSUS CASPOFUNGIN FOR THE TREATMENT OF CANDIDIASTIC ESOPHAGITIS
FUJISAWA HEALTH CARE INC,0 个研究点目标入组 0 人开始时间: 2004年7月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Esophageal candidiasis confirmed by endoscopy
- •Negative pregnancy test for female patients of childbearing potential
排除标准
- •Pregnant or nursing female patient
- •Evidence of liver disease
- •Another active opportunistic fungal infection and/or receiving acute systemic therapy for an opportunistic fungal infection
- •Concomitant esophagitis caused by herpes simplex virus or cytomegalovirus
- •Received an oral or topical antifungal agent within 48 hours or a systemic antifungal agent within 72 hours of first dose of study drug
- •Known to be non-responsive to therapy in any prior systemic antifungal clinical trail
- •Experienced > 2 episodes of esophageal candidiasis requiring systemic antifungal therapy
- •History of anaphylaxis attributed to echinocandin class of antifungals
研究者
相似试验
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B37 CandidiasisB37CandidiasisPER-023-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCandidiasis-B37 CandidiasisB37PER-026-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379PER-024-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis.-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379PER-055-03FUJISAWA HEALTH CARE INC,
已完成
不适用
COMPARATIVE TRIAL OF MICAFUNGIN VERSUS FLUCONAZOLE FOR TREATING ESOPHAGEAL CANDIDIASIS.-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379PER-048-03FUJISAWA HEALTH CARE INC,